PE20070239A1 - Derivados de imidazopiridina con actividad sobre los receptores cannabinoides - Google Patents

Derivados de imidazopiridina con actividad sobre los receptores cannabinoides

Info

Publication number
PE20070239A1
PE20070239A1 PE2006000952A PE2006000952A PE20070239A1 PE 20070239 A1 PE20070239 A1 PE 20070239A1 PE 2006000952 A PE2006000952 A PE 2006000952A PE 2006000952 A PE2006000952 A PE 2006000952A PE 20070239 A1 PE20070239 A1 PE 20070239A1
Authority
PE
Peru
Prior art keywords
alkyl
imidazo
bromophenyl
pyridin
cycloalkyl
Prior art date
Application number
PE2006000952A
Other languages
English (en)
Inventor
Andrew John Eatherton
Gerard Martin Paul Giblin
Alan Naylor
Martin Edward Swarbrick
Jennifer Anne Sweeting
Lee William Page
William Leonard Mitchell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0516380A external-priority patent/GB0516380D0/en
Priority claimed from GB0524324A external-priority patent/GB0524324D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20070239A1 publication Critical patent/PE20070239A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

REFERIDA A UN COMPUESTO DE IMIDAZOPIRIDINA DE FORMULA (I), DONDE X1 ES NR4 U O; R1 ES H, ALQUILO C1-C6, CICLOALQUILO C3-C6, ENTRE OTROS; R2 ES H O (CH2)mR3; m ES 0 O 1; R3 ES UN GRUPO HETEROCICLILO DE 4 A 8 MIEMBROS NO AROMATICO, CICLOALQUILO C3-C8, FENILO, ENTRE OTROS; R6 ES FENILO, CICLOALQUILO C3-C6, ENTRE OTROS; R10 ES H, ALQUILO C1-C6, CLORO, ENTRE OTROS; R12 ES H O ALQUILO C1-C6; R13 ES H O ALQUILO C1-C6. SON COMPUESTOS PREFERIDOS: SAL HIDROCLORURO DE N-(3-BROMOFENIL)-1-METIL-7-(1-PIPERIDINILCARBONIL)-1H-IMIDAZO[4,5-c]PIRIDIN-4-AMINA, SAL HIDROCLORURO DE N-(3-BROMOFENIL)-1-METIL-7-(4-MORFOLINILCARBONIL)-1H-IMIDAZO[4,5-c]PIRIDIN-4-AMINA, SAL HIDROCLORURO DE N-(3-BROMOFENIL)-1-METIL-7-(1-PIRROLIDINILCARBONIL)-1H-IMIDAZO[4,5-c]PIRIDIN-4-AMINA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS ACTUAN SOBRE LOS RECEPTORES CANNABINOIDES CB1 Y CB2, PREFERENTEMENTE CON MAYOR SELECTIVIDAD SOBRE LOS RECEPTORES CB2, Y SON UTILES EN EL TRATAMIENTO DEL DOLOR INFLAMATORIO CRONICO, DOLOR ASOCIADO CON CANCER, DOLOR NEUROPATICO, ENTRE OTROS
PE2006000952A 2005-08-09 2006-08-07 Derivados de imidazopiridina con actividad sobre los receptores cannabinoides PE20070239A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0516380A GB0516380D0 (en) 2005-08-09 2005-08-09 Compounds
GB0524324A GB0524324D0 (en) 2005-11-29 2005-11-29 Compounds

Publications (1)

Publication Number Publication Date
PE20070239A1 true PE20070239A1 (es) 2007-04-01

Family

ID=37192394

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000952A PE20070239A1 (es) 2005-08-09 2006-08-07 Derivados de imidazopiridina con actividad sobre los receptores cannabinoides

Country Status (17)

Country Link
US (1) US20080221097A1 (es)
EP (1) EP1912985A1 (es)
JP (1) JP2009504587A (es)
KR (1) KR20080034457A (es)
AR (1) AR055601A1 (es)
AU (1) AU2006278191A1 (es)
BR (1) BRPI0614272A2 (es)
CA (1) CA2618165A1 (es)
CR (1) CR9787A (es)
EA (1) EA200800562A1 (es)
IL (1) IL188924A0 (es)
MA (1) MA29694B1 (es)
MX (1) MX2008001935A (es)
NO (1) NO20081195L (es)
PE (1) PE20070239A1 (es)
TW (1) TW200734335A (es)
WO (1) WO2007017237A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0705803D0 (en) * 2007-03-28 2007-05-02 Glaxo Group Ltd Novel compounds
US8524727B2 (en) 2009-03-30 2013-09-03 Astellas Pharma Inc. Pyrimidine compound
AU2011213621A1 (en) 2010-02-08 2012-08-30 Allergan, Inc. Pyridazine derivatives useful as cannabinoid - 2 agonists
PT2599774T (pt) * 2010-07-29 2016-09-23 Astellas Pharma Inc Compostos de piridina condensados como ligandos do recetor canabinoide cb2

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113245B1 (en) * 1982-12-29 1989-03-15 Kureha Kagaku Kogyo Kabushiki Kaisha Cephalosporin derivatives
US5112820A (en) * 1990-03-05 1992-05-12 Sterling Drug Inc. Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US6696448B2 (en) * 1996-06-05 2004-02-24 Sugen, Inc. 3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
ATE237023T1 (de) * 1998-01-23 2003-04-15 Voith Paper Patent Gmbh Verfahren zur entfernung von feinen verunreinigungen aus einer faserstoffsuspension
US6232320B1 (en) * 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
US7332494B2 (en) * 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
EP1315741A2 (en) * 2000-09-06 2003-06-04 Ortho-McNeil Pharmaceutical, Inc. A method for treating allergies
US20040063744A1 (en) * 2002-05-28 2004-04-01 Tao Wang Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
DE60308699T2 (de) * 2002-08-21 2007-08-23 Glaxo Group Ltd., Greenford 2-phenylamino-4-trifluoromethyl-5-(benzyl- oder pyridin-4-ylmethyl)carbamoylpyrimidin-derivate als selektive cb2 cannabinoid-rezeptor modulatoren
GB0222493D0 (en) * 2002-09-27 2002-11-06 Glaxo Group Ltd Compounds
TW200418830A (en) * 2003-02-14 2004-10-01 Wyeth Corp Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
US20040214856A1 (en) * 2003-04-23 2004-10-28 Pfizer Inc Cannabinoid receptor ligands and uses thereof
KR20070034049A (ko) * 2004-06-09 2007-03-27 글락소 그룹 리미티드 피롤로피리딘 유도체

Also Published As

Publication number Publication date
BRPI0614272A2 (pt) 2011-03-22
NO20081195L (no) 2008-04-28
WO2007017237A1 (en) 2007-02-15
TW200734335A (en) 2007-09-16
MX2008001935A (es) 2008-03-26
MA29694B1 (fr) 2008-08-01
CR9787A (es) 2008-05-05
IL188924A0 (en) 2008-08-07
KR20080034457A (ko) 2008-04-21
AU2006278191A1 (en) 2007-02-15
AR055601A1 (es) 2007-08-29
EP1912985A1 (en) 2008-04-23
JP2009504587A (ja) 2009-02-05
US20080221097A1 (en) 2008-09-11
EA200800562A1 (ru) 2008-06-30
CA2618165A1 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
TW200744587A (en) Azaindole derivatives exhibiting PGD2 receptor antagonism
PE20061305A1 (es) Compuestos derivados de fenilacetamidas como inhibidores de proteincinasas
PE20040197A1 (es) Pirazolopiridinas sustituidas con carbamato
ECSP056115A (es) ANTAGONISTAS DEL RECEPTOR A2a DE 2-ALQUINIL- Y 2-ALQUENIL-PIRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PIRIMIDINA ADENOSINA
PE20170003A1 (es) Compuestos heterociclicos y usos de los mismos
AR052458A1 (es) Amino-imidazolonas para la inhibicion de beta-secretasa
AR057380A1 (es) Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
AR064608A1 (es) Derivados de pirazolo-quinazolina sustituidos, composiciones farmaceuticas que los contienen. proceso para su preparacion y uso de los mismos como agentes anticancer.
AR053120A1 (es) Aminopiridinas como inhibidores de beta secretasa
TW200734322A (en) Indole derivatives exhibiting PGD2 receptor antagonism
PE20090648A1 (es) Compuestos para el tratamiento de la hepatitis c
PE20191495A1 (es) Piridonamidas como moduladores de canales de sodio
ECSP055636A (es) Acidos tienil-hidroxamicos sustituidos, y su uso para tratar enfermedades asociadas con la actividad enzimatica de la histona desacetilasa
CY1110979T1 (el) Παραγωγα κιναζολινης ως αναστολεις αγγειογενεσης και ενδιαμεσες ενωσεις αυτων
AR047098A1 (es) Derivados de arilanilina como agonistas del receptor adrenergico beta2
PE20061378A1 (es) INHIBIDORES DE LA ACTIVIDAD DE Akt
AR030186A1 (es) Compuesto antibacteriano 3-aminoquinazolina-2,4-diona, composicion farmaceutica que lo comprende y su uso para fabricarla
AR037243A1 (es) Antagonistas del receptor de adenosina a2a,a5-amino-imidazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]pirimidina, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
AR046711A1 (es) 5-7-diaminopirazolo[4,3d]pirimidinas como inhibidores de la pde-5,composiciones farmaceuticas que las contienen y usos en el tratamiento de hipertensiones
AR068057A1 (es) Esteres de 1-fenil-2-(3,5-dicloro)-piridina, metodo de preparacion de los mismos, composiciones farmaceuticas que los contienen y usos de los mismos para el tratamiento de enfermedades del tracto respiratorio.
ECSP088731A (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
AR047466A1 (es) Compuestos derivados de 3h - imidazo[4,5 - b]piridina con actividad inhibidora de quinasa, composiciones farmacéuticas que los contienen como principio activo y su uso en la fabricacion de un medicamento para el tratatmiento de neoplasmas susceptibles.
MA54755A (fr) Dérivés d'imidazo[1,2-a]pyridinyle servant d'inhibiteurs d'irak4
AR074608A1 (es) Derivados de 2-(piperidin-1-il)-4-heterociclil-tiazol-5-carboxilico para infecciones bacterianas
AR070648A1 (es) Derivados de bencimidazol sustituido

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
AE Restoration of lapsed or forfeited application
FC Refusal